Login / Signup

Use of oral rivaroxaban in cerebral venous thrombosis.

Muhammad MaqsoodMuhammad Imran Hasan KhanMubashar YameenKashif Aziz AhmedNazim HussainSafdar Hussain
Published in: Journal of drug assessment (2020)
Rivaroxaban is a safe option in CVT however; larger randomized controlled studies will impact the results validity.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • pulmonary embolism
  • double blind
  • open label
  • placebo controlled
  • subarachnoid hemorrhage
  • phase iii
  • case control
  • clinical trial
  • brain injury
  • cerebral blood flow